
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Res</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32795361</article-id><article-id pub-id-type="pmc">7427901</article-id><article-id pub-id-type="publisher-id">824</article-id><article-id pub-id-type="doi">10.1186/s13567-020-00824-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Disruption of pyruvate phosphate dikinase in <italic>Brucella ovis</italic> PA CO<sub>2</sub>-dependent and independent strains generates attenuation in the mouse model</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vizca&#x000ed;no</surname><given-names>Nieves</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;rez-Etayo</surname><given-names>Lara</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Conde-&#x000c1;lvarez</surname><given-names>Raquel</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Iriarte</surname><given-names>Maite</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Moriy&#x000f3;n</surname><given-names>Ignacio</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7865-8994</contrib-id><name><surname>Z&#x000fa;&#x000f1;iga-Ripa</surname><given-names>Amaia</given-names></name><address><email>azuniga@unav.es</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.11762.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 1817</institution-id><institution>Departamento de Microbiolog&#x000ed;a Y Gen&#x000e9;tica, Edificio Departamental, </institution><institution>Universidad de Salamanca, </institution></institution-wrap>Edificio Departamental, Plaza Doctores de la Reina s/n, Salamanca, 37007 Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411258.b</institution-id><institution>Instituto de Investigaci&#x000f3;n Biom&#x000e9;dica de Salamanca (IBSAL), </institution><institution>Hospital Universitario de Salamanca, </institution></institution-wrap>Paseo de San Vicente 52-182, 37007 Salamanca, Spain </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.5924.a</institution-id><institution-id institution-id-type="ISNI">0000000419370271</institution-id><institution>Instituto de Salud Tropical (ISTUN), Instituto de Investigaci&#x000f3;n Sanitaria de Navarra (IdiSNA), Departamento de Microbiolog&#x000ed;a y Parasitolog&#x000ed;a, </institution><institution>Universidad de Navarra, </institution></institution-wrap>Calle Irunlarrea 1, 31008 Pamplona, Spain </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="ppub"><year>2020</year></pub-date><volume>51</volume><elocation-id>101</elocation-id><history><date date-type="received"><day>7</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><p id="Par1"><italic>Brucella ovis</italic> is a non-zoonotic rough <italic>Brucella</italic> that causes genital lesions, abortions and increased perinatal mortality in sheep and is responsible for important economic losses worldwide. Research on virulence factors of <italic>B. ovis</italic> is necessary for deciphering the mechanisms that enable this facultative intracellular pathogen to establish persistent infections and for developing a species-specific vaccine, a need in areas where the cross-protecting ovine smooth <italic>B. melitensis</italic> Rev1 vaccine is banned. Although several <italic>B. ovis</italic> virulence factors have been identified, there is little information on its metabolic abilities and their role in virulence. Here, we report that deletion of pyruvate phosphate dikinase (PpdK, catalyzing the bidirectional conversion pyruvate &#x021cc; phosphoenolpyruvate) in <italic>B. ovis</italic> PA (virulent and CO<sub>2</sub>-dependent) impaired growth in vitro. In cell infection experiments, although showing an initial survival higher than that of the parental strain, this <italic>ppdK</italic> mutant was unable to multiply. Moreover, when inoculated at high doses in mice, it displayed an initial spleen colonization higher than that of the parental strain followed by a marked comparative decrease, an unusual pattern of attenuation in mice. A homologous mutant was also obtained in a <italic>B. ovis</italic> PA CO<sub>2</sub>-independent construct previously proposed for developing <italic>B. ovis</italic> vaccines to solve the problem that CO<sub>2</sub>-dependence represents for large scale production. This CO<sub>2</sub>-independent <italic>ppdK</italic> mutant reproduced the growth defect in vitro and the multiplication/clearance pattern in mouse spleens, and is thus an interesting vaccine candidate for the immunoprophylaxis of <italic>B. ovis</italic> ovine brucellosis.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Brucella ovis</italic></kwd><kwd>metabolism</kwd><kwd>gluconeogenesis</kwd><kwd>pyruvate phosphate dikinase</kwd><kwd>attenuation</kwd><kwd>laboratory models</kwd><kwd>vaccine</kwd><kwd>virulence</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003329</institution-id><institution>Ministerio de Econom&#x000ed;a y Competitividad</institution></institution-wrap></funding-source><award-id>AGL2014-58795-C4-4-R</award-id><award-id>AGL2014-58795-C4-1-R</award-id><principal-award-recipient><name><surname>Vizca&#x000ed;no</surname><given-names>Nieves</given-names></name><name><surname>Moriy&#x000f3;n</surname><given-names>Ignacio</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Fondo Europeo de Desarrollo Regional</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Instituto de Salud Tropical</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; L'Institut National de Recherche en Agriculture, Alimentation et Environnement (INRAE) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par19">Brucellosis is an infectious disease caused by several species of the intracellular gram-negative pathogen <italic>Brucella</italic> spp. This disease affects domestic and wild animals and can be transmitted to humans, producing important economic losses and human suffering in many countries throughout the world [<xref ref-type="bibr" rid="CR1">1</xref>]. Currently, these bacteria are grouped in a single genus with up to 12 nominal species that often show host preference (<ext-link ext-link-type="uri" xlink:href="https://lpsn.dsmz.de/genus/brucella">https://lpsn.dsmz.de/genus/brucella</ext-link>). The zoonotic brucellae that infect cattle (<italic>B. abortus</italic>), swine (<italic>B. suis</italic> biovars 1, 2, and 3) and goats and sheep (<italic>B. melitensis</italic>) carry a smooth lipopolysaccharide (LPS) and have deserved greater attention because of their great impact on public health and animal production. Sheep can also be infected by <italic>B. ovis</italic>, a non-zoonotic species that causes ovine epididymitis and is naturally rough (i.e. bears an LPS lacking the O-polysaccharide section) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. <italic>B. ovis</italic> is considered one of the most important causes of ovine infertility and has a significant economic impact on sheep husbandry [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par20">Animal vaccination is the most suitable method for controlling brucellosis in areas with moderate to high prevalence of the disease. Since sheep brucellosis can be caused by either <italic>B. melitensis</italic> or <italic>B. ovis</italic> and no specific vaccine against <italic>B. ovis</italic> is available, the attenuated vaccine <italic>B. melitensis</italic> Rev1 has been used to control infections by both bacteria. However, this vaccine has several drawbacks [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>], among them its virulence for humans and an induction of persistent antibodies against the LPS O-polysaccharide [<xref ref-type="bibr" rid="CR9">9</xref>]. Since this is the antigen used in the diagnosis of <italic>B. melitensis</italic> infections, those antibodies hamper the discrimination of Rev1 vaccinated and <italic>B. melitensis</italic> infected animals. Owing to this drawback, Rev1 is banned in regions or countries where <italic>B. melitensis</italic> has been eradicated [<xref ref-type="bibr" rid="CR10">10</xref>], thus favoring the emergence of <italic>B. ovis</italic> infections. Therefore, research on vaccines on a <italic>B. ovis</italic> background is of great interest as such species-specific vaccines would neither interfere in <italic>B. melitensis</italic> serological tests nor cause human infections [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par21">Current live attenuated brucellosis vaccines reproduce closely the cell invasion, intracellular trafficking and antigen presentation of virulent brucellae [<xref ref-type="bibr" rid="CR14">14</xref>] and are thus the best vaccines available against <italic>B. abortus</italic> and <italic>B. melitensis</italic> [<xref ref-type="bibr" rid="CR15">15</xref>]. Indeed, the development of new attenuated vaccines depends on an understanding of the virulence factors involved in infection, a topic that is delayed in <italic>B. ovis</italic> with respect to its smooth zoonotic counterparts. Several <italic>B. ovis</italic> attenuated mutants in classic <italic>Brucella</italic> virulence factors, outer membrane proteins, core LPS glycosyltransferases and an ABC transporter have been described [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>], some of them providing interesting results as potential vaccines [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. However, recent works emphasize the relevance of bacterial metabolism in the virulence of smooth <italic>Brucella</italic> species [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], an aspect of the biology of the parasite yet to be explored in <italic>B. ovis</italic>.</p><p id="Par22">In <italic>B. abortus</italic> 2308&#x000a0;W, we have shown that disruption of pyruvate phosphate dikinase (PpdK) (catalyzing the bidirectional conversion ATP&#x02009;+&#x02009;pyruvate&#x02009;+&#x02009;Pi&#x000a0;&#x021cc;&#x000a0;AMP&#x02009;+&#x02009;phosphoenolpyruvate&#x02009;+&#x02009;PPi) severely affects growth on gluconeogenic substrates and causes attenuation in mice [<xref ref-type="bibr" rid="CR26">26</xref>], strongly suggesting an important role for the phosphoenolpyruvate (PEP)-Tricarboxylic Acid Cycle (TCA) connections in virulence. Considering the great homogeneity of the <italic>Brucella</italic> genus, it seemed plausible that this metabolic step is also important in the virulence of other brucellae and, in keeping with this hypothesis, we found that attenuation occurs in a double PckA-PpdK mutant of <italic>B. suis</italic> 513, a more prototrophic biovar 5 strain that uses both PpdK and phosphoenolpyruvate carboxykinase (PckA; ATP&#x02009;+&#x02009;oxaloacetate&#x02009;&#x02192;&#x02009;ADP&#x02009;+&#x02009;CO<sub>2</sub> +&#x000a0;PEP) for PEP synthesis [<xref ref-type="bibr" rid="CR27">27</xref>]. Accordingly, the aim of this research was to investigate whether genes coding for PpdK and PckA are present in <italic>B. ovis</italic> PA and to determine their involvement in metabolism and virulence. Additionally, since the CO<sub>2</sub> requirement of <italic>B. ovis</italic> represents a significant obstacle for large-scale production of a live attenuated vaccine, we explored the possibilities of combining deletion of those metabolic genes with genetic modifications of the <italic>B. ovis</italic> carbonic anhydrases required for CO<sub>2</sub>-independent growth that we have recently deciphered [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Bacterial strains and culture conditions</title><p id="Par23"><italic>B. ovis</italic> PA is a virulent strain that, like most <italic>B. ovis</italic> strains, requires CO<sub>2</sub> for growth. It was used as the parental strain to obtain the recombinant <italic>B. ovis</italic> strains used in this work (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). <italic>B. ovis</italic> strains were cultivated at 37&#x000a0;&#x000b0;C under a 5% CO<sub>2</sub> atmosphere, except for the selection and characterization of CO<sub>2</sub>-independent strains. Tryptic soy agar (TSA) or tryptic soy broth (TSB) (Pronadisa-Laboratorios Conda), both supplemented with 0.3% yeast extract (YE) (Pronadisa-Laboratorios Conda) and 5% horse serum (HS) (Gibco-Life Technologies), were used as solid (TSA-YE-HS) and liquid (TSB-YE-HS) culture medium, respectively.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Most relevant bacterial strains used in this work.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>Brucella ovis</italic> strains<sup>a</sup></th><th align="left">Main characteristics</th><th align="left">Source</th></tr></thead><tbody><tr><td align="left"><italic>B. ovis</italic> PA</td><td align="left">Virulent parental strain; CO<sub>2</sub>-dependent</td><td align="left">BCCN (76-250)</td></tr><tr><td align="left"><italic>Bov</italic>::CA</td><td align="left"><italic>B. ovis</italic> PA carrying Tn7<sub>Ba2308W</sub>CAI<sub>Ba2308W</sub>CAII; CO<sub>2</sub>-independent</td><td align="left">This work</td></tr><tr><td align="left"><italic>Bov</italic>&#x00394;<italic>ppdK</italic></td><td align="left">Derived from <italic>B. ovis</italic> PA; <italic>ppdK</italic> deletion; CO<sub>2</sub>-dependent</td><td align="left">This work</td></tr><tr><td align="left"><italic>Bov</italic>&#x00394;<italic>ppdK</italic> pAZI-19</td><td align="left"><italic>Bov</italic>&#x00394;<italic>ppdK</italic> complemented in trans with <italic>ppdK</italic> gene cloned into pRH001; CO<sub>2</sub>-dependent</td><td align="left">This work</td></tr><tr><td align="left"><italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic></td><td align="left">Derived from <italic>Bov</italic>::CA; <italic>ppdK</italic> deletion; CO<sub>2</sub>-independent</td><td align="left">This work</td></tr><tr><td align="left"><italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic> pAZI-19</td><td align="left"><italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic> complemented in trans with <italic>ppdK</italic> gene cloned into pRH001; CO<sub>2</sub>-independent</td><td align="left">This work</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>The <italic>B. ovis</italic> recombinant strains derive from <italic>B. ovis</italic> PA, which was obtained from BCCN (<italic>Brucella</italic> Culture Collection Nouzilly, Institut National de la Recherche Agronomique, Nouzilly, France).</p></table-wrap-foot></table-wrap></p><p id="Par24">To study the metabolic phenotype of the <italic>B. ovis</italic> strains, the gluconeogenic minimal medium of Gerhardt and Wilson (referred to here as Gerhardt) was used [<xref ref-type="bibr" rid="CR29">29</xref>]. Growth was also tested on this medium supplemented with 5% horse serum (Gerhardt-HS), 5% horse serum and methionine 1&#x000a0;mM (Gerhardt-HS-meth) or the latter adding a mixture of vitamins provided by the RPMI supplement R7256 (Sigma Aldrich) (Gerhardt-HS-meth-vit). The composition of the different defined media is detailed in Additional file <xref rid="MOESM1" ref-type="media">1</xref>. The pH was adjusted to 7.</p><p id="Par25">When required, media were supplemented with 5% sucrose (Sigma) or with kanamycin (Km; 50&#x000a0;&#x003bc;g/mL) and/or nalidixic acid (Nal; 25&#x000a0;&#x003bc;g/mL) (Sigma). All strains were stored at &#x02212;80&#x000a0;&#x000b0;C in TSB-YE-HS with 7% DMSO.</p></sec><sec id="Sec4"><title>DNA manipulations and analysis</title><p id="Par26">Genomic sequences were obtained from the database National Center for Biotechnology Information (NCBI) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Searches for DNA and protein homologies were carried out using NCBI BLAST [<xref ref-type="bibr" rid="CR30">30</xref>]. Sequence alignments were performed with Clustal Omega [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Plasmid DNA was extracted with QIAprep Spin Miniprep (Qiagen). PCR amplification for verification of genetically modified <italic>B. ovis</italic> strains was performed with Red Taq DNA polymerase master mix (VWR, Leuven, Belgium).</p></sec><sec id="Sec5"><title>Plasmids and mutagenesis</title><p id="Par27">Construction of the <italic>ppdK</italic> mutants was done using previously described plasmid [<xref ref-type="bibr" rid="CR26">26</xref>] and strategy [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Briefly, to obtain the in-frame <italic>ppdK</italic> mutant (<italic>Bov</italic>&#x00394;<italic>ppdK)</italic>, the suicide plasmid pMZI-2 was introduced into <italic>B. ovis</italic> PA and both the deletion mutant and the sibling revertant strain generated by allelic exchange were selected by sucrose resistance and Km sensitivity and by PCR using external and internal primers to the deleted fragment. The mutation generated resulted in the loss of the 93% of <italic>ppdK</italic> (BOV_RS02525 locus of the <italic>B. ovis</italic> 63/290 genome; accession numbers NC_009505 and NC_009504 for chromosome I and II, respectively).</p><p id="Par28">The CO<sub>2</sub>-independent strain <italic>Bov</italic>::CA was obtained using previously described strategy [<xref ref-type="bibr" rid="CR28">28</xref>]. Briefly, the genes coding for the CAI and CAII carbonic anhydrases of the CO<sub>2</sub>-independent strain <italic>B. abortus</italic> 2308&#x000a0;W were cloned into vector pUC18R6KT-miniTn7-Km<sup>R</sup> [<xref ref-type="bibr" rid="CR33">33</xref>]. The recombinant plasmid was introduced in <italic>B. ovis</italic> PA and the desired <italic>Bov</italic>::CA strain (containing both CA genes inserted in the genome between <italic>glmS</italic> and <italic>recG</italic>) was selected according to previously described procedures [<xref ref-type="bibr" rid="CR28">28</xref>]. Kanamycin resistance cassette was deleted following the protocol set up by Mart&#x000ed;nez-G&#x000f3;mez et al. [<xref ref-type="bibr" rid="CR34">34</xref>]. Finally, to obtain the CO<sub>2</sub>-independent <italic>ppdK</italic> mutant (<italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic>), the suicide plasmid pMZI-2 was introduced into <italic>Bov</italic>::CA following the procedure described above.</p><p id="Par29"><italic>In trans</italic> complementation of both mutants with wild-type <italic>ppdK</italic> (<italic>Bov</italic>&#x00394;<italic>ppdK</italic> pAZI-19 and <italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic> pAZI-19) was performed with plasmid pAZI-19 [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec6"><title>Bacterial growth evaluation</title><p id="Par30">Growth curves in TSB-YE-HS were stablished for all strains from initial bacterial suspensions with an optical density (OD<sub>600</sub>) of 0.05 in 30&#x000a0;mL of culture medium that were incubated under agitation (120&#x000a0;rpm). OD<sub>600</sub> values were determined through a 120-h period.</p><p id="Par31">Growth evaluation in minimal media was performed as follows. CO<sub>2</sub>-independent <italic>B. ovis</italic> PA was inoculated into 10&#x000a0;mL of TSB-YE-HS in a 50-mL flask and incubated at 37&#x000a0;&#x000b0;C with orbital shaking for 18&#x000a0;h. These exponentially growing bacteria were harvested by centrifugation, resuspended in 5&#x000a0;mL of each test medium at an OD<sub>600</sub> of 0.1, and incubated at 37&#x000a0;&#x000b0;C with orbital shaking for 18&#x000a0;h. Then, these preconditioned bacteria were harvested by centrifugation, resuspended at an OD<sub>600</sub> of 0.1 in the same test medium in Bioscreen multiwell plates (200 &#x003bc;L/well), and incubated in a Bioscreen C (Lab Systems) apparatus with continuous shaking at 37&#x000a0;&#x000b0;C. Absorbance values at 420&#x02013;580&#x000a0;nm were automatically recorded at 0.5-h intervals over a 300-h period. All experiments were performed in triplicate. Controls with medium and no bacteria were included in all experiments.</p></sec><sec id="Sec7"><title>Cell infection assays</title><p id="Par32">Internalization and intracellular survival in J774.A1 murine macrophage-like cell line (DSMZ ACC170) and epithelial HeLa cells (ATCC CCL-2TM) were evaluated according to previously described protocols [<xref ref-type="bibr" rid="CR35">35</xref>]. Briefly, cell lines were cultured for 24&#x000a0;h in 96-well sterile plates at 37&#x000a0;&#x000b0;C under a 5% CO<sub>2</sub> atmosphere (2&#x02009;&#x000d7;&#x02009;10<sup>4</sup> J744.A1 cells/well or 1.5 x 10<sup>4</sup> HeLa cells/well) and infected with the different <italic>B. ovis</italic> strains (4 x 10<sup>6</sup>&#x000a0;CFU/well for macrophages or 8 x 10<sup>6</sup>&#x000a0;CFU/well for HeLa cells). Bacteria were discarded after 2-h incubation, and gentamycin was added to kill extracellular bacteria. After 1-h incubation, three wells per <italic>B. ovis</italic> strain were washed to remove gentamycin, eukaryotic cells were lysed by incubation with H<sub>2</sub>O, and intracellular bacteria were enumerated by platting serial dilutions of the content of the wells on TSA-YE-HS [t0 post-infection (p.i.)]. The remaining wells were maintained in the presence of gentamycin and three wells per strain were similarly processed to determine intracellular bacteria at t20 and t44 p.i. The results were expressed as mean&#x02009;&#x000b1;&#x02009;SD of the log CFU/well at each time point and are representative of three independent experiments.</p></sec><sec id="Sec8"><title>Mouse assays and ethics statement</title><p id="Par33">In vivo virulence experiments were performed with female 6-week-old BALB/c mice (Charles River Laboratories, France), received 1&#x000a0;week before, that were kept with water and food ad libitum at registered facilities of the University of Salamanca (PAE SA-001). All procedures involving animals were designed according to Spanish and European laws regarding the use of animals in research (RD 53/2013 and directive 2010/63/UE). They were approved by the Bioethics Committee of the University of Salamanca and authorized by the competent authority of &#x0201c;Junta de Castilla y Le&#x000f3;n&#x0201d;, Spain. Microbiological protocols were approved by the Biosecurity Committees of the Universities of Salamanca and Navarra.</p><p id="Par34">In the first experiment, mice were inoculated by the intraperitoneal route with 10<sup>6</sup> or 10<sup>8</sup>&#x000a0;CFU of <italic>B. ovis</italic> PA or <italic>Bov</italic>&#x00394;<italic>ppdK</italic> in 200&#x000a0;&#x000b5;L of phosphate buffered saline (PBS). Bacterial splenic colonization was determined in five mice per group at weeks 3 and 11 p.i. as previously described [<xref ref-type="bibr" rid="CR20">20</xref>]. These time points were chosen because, in the parental strain week 3 corresponds to the acute phase of infection (highest numbers of splenic bacteria) while week 11 corresponds to a point of the chronic phase when a decrease of CFU in spleen is observed [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par35">Subsequently, the level of splenic infection was determined at weeks 1, 3, 5, 7 and 11 in mice inoculated with 10<sup>8</sup>&#x000a0;CFU of the CO<sub>2</sub>-dependent (<italic>B. ovis</italic> PA and <italic>Bov</italic>&#x00394;<italic>ppdK</italic>) and CO<sub>2</sub>-independent (<italic>Bov</italic>::CA and <italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic>) strains. The complemented mutant strains (<italic>Bov</italic>&#x00394;<italic>ppdK</italic> pAZI-19 and <italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic> pAZI-19) were also evaluated at weeks 1, 3, 7 and 11.</p></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par36">Statistical comparisons between means were performed with one-way ANOVA and the Fisher&#x000b4;s Least Significant Differences test of GraphPad Prism Software (GraphPad Software Inc., San Diego, USA). Statistically significant differences (<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.01) were established with a 99% confidence interval.</p></sec></sec><sec id="Sec10"><title>Results</title><sec id="Sec11"><title>Comparison of <italic>pckA</italic> and <italic>ppdK</italic> orthologues</title><p id="Par37">Concerning <italic>pckA</italic>, <italic>B. ovis</italic> 63/290 BOV_RS09880 is annotated as a pseudogene that hypothetically encodes a protein of 458 amino acids, shorter than the 536-amino acid PckA proteins encoded by <italic>Agrobacterium tumefaciens</italic> C58 (ATU_RS00170) and <italic>B. suis</italic> 513 (genome without annotation, contig accession number ACBK01000073), both previously shown to be functional [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. The <italic>B. ovis</italic> 63/290 putative PckA enzyme keeps the specific domain (IGGTSYAGE-KKS; 190 to 202) required for its activity (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). The phosphate-binding (G&#x02013;G-GKT) and adenine-binding (IIML&#x02013;D) consensus sites of ATP-dependent proteins (residues 233 to 243 and 345 to 351, respectively) as well as a metal ion binding (G&#x02014;EG) site (residues 265 to 271) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] are also conserved (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). However, these domains are also present in the protein encoded by the <italic>pckA</italic> ortholog of <italic>B. abortus</italic> 2308&#x000a0;W (BAB1_2091), which encodes an inactive protein of 491 amino acids because of a premature stop codon [<xref ref-type="bibr" rid="CR26">26</xref>] (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). Similar to <italic>B. abortus</italic>, deletion of a cytosine at position 1523 in <italic>B. ovis pckA</italic> alters the reading frame and thus only the first 418 amino acids are conserved when compared to <italic>B. suis</italic> 513 (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). Accordingly, PckA is not expected to be functional in <italic>B. ovis</italic>, as previously suggested by Tsolis et al. [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par38">A search of the <italic>B. ovis</italic> 63/290 genome revealed that the locus BOV_RS02525 putatively encodes PpdK. The predicted protein has 887 amino acids, where residues 19 to 376 contain a PEP-binding domain and amino acids 530 to 883 form the TIM-barrel domain characteristic of PEP-utilizing enzymes. When comparing this protein with its homologues in <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> 513, both functional [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>], only 3 amino acid changes were found: A177V, V312E, C857Y (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). Also, an alanine present at position 605 in <italic>B. suis</italic> 513 and <italic>B. ovis</italic> 63/290 is substituted by a glycine in <italic>B. abortus</italic> 2308&#x000a0;W (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). Therefore, PpdK should also be functional in <italic>B. ovis</italic> and, accordingly, <italic>ppdK</italic> mutants were constructed in CO<sub>2</sub>-dependent and CO<sub>2</sub>-independent virulent <italic>B. ovis</italic> PA.</p></sec><sec id="Sec12"><title>Growth characteristics of <italic>B. ovis</italic> mutants</title><p id="Par39">Growth in TSB-YE-HS showed no differences between the CO<sub>2</sub>-dependent and -independent strains (Figure &#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). However, although both <italic>ppdK</italic> mutants did not show a marked delayed growth during the first 20&#x000a0;h of incubation, their growth drastically slowed down after that moment, with comparatively reduced maximum OD<sub>600</sub> scores when compared to their parental strains (Figure &#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Since complementation with plasmid pAZI-19 carrying <italic>ppdK</italic> restored the wild-type phenotype (Figure &#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), these results clearly indicate a role for PpdK in <italic>B. ovis</italic> PA metabolism under these in vitro conditions.<fig id="Fig1"><label>Figure &#x000a0;1</label><caption><p><bold>Growth of the</bold>
<bold><italic>B. ovis</italic></bold>
<bold>strains in TSB-YE-HS</bold>. Growth was evaluated by measuring the evolution over time of the OD<sub>600</sub> values in TSB-YE-HS liquid medium of CO<sub>2</sub>-dependent strains (<bold>A</bold>) and CO<sub>2</sub>-independent strains (<bold>B</bold>). Results are representative of two independent experiments.</p></caption><graphic xlink:href="13567_2020_824_Fig1_HTML" id="MO1"/></fig></p><p id="Par40">As indicated in the Introduction, PpdK catalyzes a bidirectional reaction that can thus be involved in gluconeogenesis when bacteria grow on 3 and 4 C substrates, a function that should be shared by <italic>B. ovis</italic> PpdK [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. However, although <italic>B. abortus</italic>, <italic>B. melitensis</italic> and <italic>B. suis</italic> grow on glutamate-lactate-glycerol (Gerhardt&#x02019;s medium) [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR39">39</xref>], to investigate the gluconeogenic role of PpdK in <italic>B. ovis</italic> PA it was first necessary to examine the ability of this strain to grow in Gerhardt&#x02019;s medium (Additional file <xref rid="MOESM1" ref-type="media">1</xref>). Among brucellae <italic>B. ovis</italic> is notoriously fastidious and requires serum even in rich media. Thus, a first attempt was made by supplementing Gerhardt&#x02019;s medium with 5% horse serum (Gerhardt-HS, Additional file <xref rid="MOESM1" ref-type="media">1</xref>). However, <italic>B. ovis</italic> PA did not grow in this medium. Some <italic>Brucella</italic> strains require methionine to grow in minimal media [<xref ref-type="bibr" rid="CR25">25</xref>], but when this amino acid was also added to Gerhardt-HS (Gerhardt-HS-meth, Additional file <xref rid="MOESM1" ref-type="media">1</xref>) the combination did not support growth of <italic>B. ovis</italic> PA either. Finally, since brucellae show variable auxotrophy for some vitamins, the effect of the vitamin-rich RMPI supplement R7256 was also tested (Gerhardt-HS-meth-vit, Additional file <xref rid="MOESM1" ref-type="media">1</xref>). Again, no growth was observed in this medium. These results, that show that <italic>B. ovis</italic> PA is more auxotrophic than other brucellae and are in agreement with the comparative genome degradation of this species [<xref ref-type="bibr" rid="CR38">38</xref>], preclude to assess whether the growth defect observed in rich medium corresponds to a shutdown of fueling of C precursors to the TCA (i.e. a catabolic role) or, on the contrary, to a gluconeogenic flux from TCA to the triose-phosphate pathway.</p></sec><sec id="Sec13"><title>Virulence in cellular models</title><p id="Par41">Since <italic>B. ovis</italic> is an intracellular pathogen, J774.A1 murine macrophages were used to determine the relevance of PpdK for intracellular survival and multiplication of <italic>B. ovis</italic> PA, <italic>Bov</italic>&#x00394;<italic>ppdK</italic> (CO<sub>2</sub>-dependent) and <italic>Bov</italic>::CA&#x00394;<italic>ppdK</italic> (CO<sub>2</sub>-independent) mutants, together with the respective parental strains and the mutant strains complemented with wild-type <italic>ppdK</italic>, were included in the study. No statistically significant differences of internalization in J744.A1 macrophages were observed among the CO<sub>2</sub>-dependent (Figure &#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A) and -independent strains (Figure &#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B). However, while the usual decrease [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR40">40</xref>] of about 1 log unit in intracellular CFU numbers was observed after 20&#x000a0;h for the parental and complemented strains, both <italic>ppdK</italic> mutants maintained the intracellular values observed at the beginning of the experiment (Figure &#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A, B). As expected, intracellular replication of parental and complemented strains was observed after 20&#x000a0;h (<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.0005), with intracellular CFU counts close to those at the beginning. Interestingly, although the <italic>ppdK</italic> mutants were not killed, their intracellular CFU numbers were similar at 20 and 44&#x000a0;h (Figure &#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A, B), showing that they barely multiplied.<fig id="Fig2"><label>Figure &#x000a0;2</label><caption><p><bold>Behaviour of the</bold>
<bold><italic>B. ovis</italic></bold>
<bold>strains in J774.A1 murine macrophages (A, B) and HeLa cells (C).</bold> Cells were infected with CO<sub>2</sub>-dependent strains (<bold>A</bold>, <bold>C</bold>) or CO<sub>2</sub>-independent strains (<bold>B</bold>) and the intracellular CFU evaluated a t0, t20 and t44 as described in Materials and Methods. The results are expressed as mean&#x02009;&#x000b1;&#x02009;SD of the log CFU/well and are representative of three independent experiments. Statistically significant differences (<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.01) with the corresponding parental strain are marked with asterisks (<italic>*P&#x02009;</italic>&#x02264;0.01, **<italic>P&#x02009;</italic>&#x02264;&#x02009;0.005; ***<italic>P&#x02009;</italic>&#x02264;&#x02009;0.0005).</p></caption><graphic xlink:href="13567_2020_824_Fig2_HTML" id="MO2"/></fig></p><p id="Par42">Considering the striking phenotype in macrophages, this part of the study was extended to evaluate the behavior of the CO<sub>2</sub>-dependent strains in a non-professional phagocyte (HeLa epithelial cells). In agreement with previous works with <italic>B. ovis</italic> PA [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR40">40</xref>], the parental and complemented strains gave the expected pattern in HeLa cells (Figure &#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). As observed in J774.A1 macrophages, whereas intracellular counts of the <italic>ppdK</italic> mutant did not decrease at 20&#x000a0;h and were significantly higher (<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.01) than those of the parental strain, they did not increase significantly from 20 to 44&#x000a0;h (Figure &#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C).</p></sec><sec id="Sec14"><title>Virulence in mice</title><p id="Par43">In a first experiment, parental <italic>B. ovis</italic> PA and its <italic>ppdK</italic> mutant were inoculated in mice at 10<sup>6</sup> or 10<sup>8</sup>&#x000a0;CFU/mouse to assess spleen colonization after 3 and 11&#x000a0;weeks. At p.i. week 3, mice inoculated with 10<sup>6</sup>&#x000a0;CFU of the <italic>ppdK</italic> mutant showed splenic counts c.a. 2 log units lower (<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.0005) than those of the parental strain (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A). At p.i. week 11 (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A), the attenuation of the <italic>ppdK</italic> mutant became more evident because, while the parental strain yielded splenic counts in the order of 4.5 log units, bacterial counts were beyond detection in the spleens of mice inoculated with the <italic>ppdK</italic> mutant (limit of detection of this method&#x02009;=&#x02009;3.3&#x000a0;CFU/mL of the homogenized spleen [<xref ref-type="bibr" rid="CR41">41</xref>]). Similar results were observed with the higher dose of inoculation, although in this case a few colonies of the <italic>ppdK</italic> mutant were detected in one mouse at p.i. week 11 (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B).<fig id="Fig3"><label>Figure &#x000a0;3</label><caption><p><bold>Spleen colonization kinetics of strains derived from CO</bold><sub><bold>2</bold></sub><bold>-dependent (A&#x02013;C) and CO</bold><sub><bold>2</bold></sub><bold>-independent (D)</bold>&#x000a0;<bold><italic>B. ovis</italic></bold>&#x000a0;<bold>PA</bold>.&#x000a0;In a first experiment (<bold>A</bold>, <bold>B</bold>), animals were inoculated with 10<sup>6</sup>&#x000a0;CFU (A) or 10<sup>8</sup>&#x000a0;CFU (B) of&#x000a0;<italic>B. ovis</italic>&#x000a0;PA or the&#x000a0;<italic>ppdK</italic>&#x000a0;mutant. The results are expressed as mean&#x02009;&#x000b1;&#x02009;SD of the log CFU/spleen (n&#x02009;=&#x02009;5) detected for each strain at weeks 3 and 11 p.i. In a second experiment (<bold>C</bold>, <bold>D</bold>), mice were inoculated with 10<sup>8</sup>&#x000a0;CFU of the CO<sub>2</sub>-dependent and CO<sub>2</sub>-independent strains and bacterial CFU were determined in spleen at weeks 1, 3, 5, 7 and 11 p.i. The results are expressed as mean&#x02009;&#x000b1;&#x02009;SD of the log CFU/spleen (n&#x02009;=&#x02009;5) detected for each strain. For each time point, statistically significant differences (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01), when compared to mice inoculated with the corresponding parental strain, are marked with asterisks (***<italic>P</italic>&#x02009;&#x02264;&#x02009;0.0005).</p></caption><graphic xlink:href="13567_2020_824_Fig3_HTML" id="MO3"/></fig></p><p id="Par44"><italic>Brucella</italic> spleen replication profile in mice shows four phases: (i) onset or colonization phase (first 48&#x000a0;h); (ii) acute phase (from day 3 to weeks 2 to 4) where bacteria reach maximal numbers; (iii) chronic steady phase, where the bacterial numbers plateau; and (iv) chronic declining phase, when brucellae are progressively eliminated [<xref ref-type="bibr" rid="CR41">41</xref>]. When intraperitoneally inoculated, and with small differences depending on the inoculation dose, <italic>B. ovis</italic> PA reaches the highest bacterial load in spleen after 3 to 4&#x000a0;weeks, the plateau phase continues until week 9 and then bacterial numbers decrease [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Using this model, a splenic colonization curve covering weeks 1 to 11 was obtained for all <italic>B. ovis</italic> strains inoculated at 10<sup>8</sup>&#x000a0;CFU/mouse. As previously reported, CO<sub>2</sub>-dependent and CO<sub>2</sub>-independent strains showed similar spleen counts throughout the experiment (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C, D) [<xref ref-type="bibr" rid="CR28">28</xref>]. Surprisingly, both <italic>ppdK</italic> mutants yielded splenic CFU counts about 2 log units higher (<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.0005) than those observed for the respective parental strains at p.i. week 1 (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C, D). However, while the CFU of the parental strains increased at p.i. week 3 and maintained similar levels of infection until week 7, the splenic CFU of the <italic>ppdK</italic> mutants underwent a progressive decrease after week 1 and were not detected in any mouse at week 11 (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C, D). Complementation of the <italic>ppdK</italic> mutants with wild type <italic>ppdK</italic> restored phenotype of the parental strains (Figure &#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C, D). Since these results show that both <italic>ppdK</italic> mutants failed to reach the chronic steady phase, they strongly suggest that PpdK activity plays a role during infection by wild-type <italic>B. ovis</italic> PA.</p></sec></sec><sec id="Sec15"><title>Discussion</title><p id="Par45">Although several works have identified genes encoding virulence factors in <italic>B. ovis</italic>, there is only indirect information on the metabolic abilities of this species and none on their connection with virulence. Thus, to gain insight into the metabolic properties of <italic>B. ovis</italic>, the enzymes related to PEP use were studied, a choice made here on the bases of their relevance in <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> 513 (reference strain of biovar 5) [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Since no <italic>Brucella</italic> genome contains a gene encoding Pps (phosphoenolpyruvate synthase), the studied candidates were PckA (phosphoenolpyruvate carboxykinase) and PpdK (pyruvate phosphate dikinase). Previous studies have shown that while <italic>B. suis</italic> 513 relies on PpdK and PckA for PEP synthesis, <italic>B. abortus</italic> 2308&#x000a0;W uses only PpdK due to an inactivating frameshift in PckA. These observations have been interpreted to mean that some pathways or reactions remain functional in species or biovars that, like the rodent-associated <italic>B. suis</italic> 513, are close to the early diverging <italic>Brucella</italic> clades while becoming inactivated in species adapted to domestic livestock [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. The results obtained in this work are in line with this interpretation because they show that the picture in <italic>B. ovis</italic> PA is similar to that of <italic>B. abortus</italic> with an inactive PckA that is even shorter [<xref ref-type="bibr" rid="CR26">26</xref>]. Why PpdK is conserved while PckA is not in some <italic>Brucella</italic> species might be related to the bidirectional nature of the enzymatic reaction catalyzed by PpdK in contrast to the role of PckA, which is involved only in the gluconeogenic direction. However, while both the genomic evidence and our experiments strongly suggest that <italic>ppdK</italic> encodes a functional enzyme catalyzing the pyruvate &#x021cc;&#x000a0;phosphoenolpyruvate reaction, we have not been able to test this prediction because of the inability of <italic>B. ovis</italic> to grow on defined media containing only glutamate-lactate-glycerol as C sources, a strategy we have used previously to confirm this activity in <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> 513 [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. It is noteworthy that deletion of <italic>ppdK</italic> in these two smooth brucellae does not affect growth in rich medium (TSB) to any extent while the homologous deletion has this effect in <italic>B. ovis</italic> when growing on TSB-YE-HS. Indeed, it is not possible presently to identify the precise reason(s) for this difference because of the inability of <italic>B. ovis</italic> to grow on simple chemically defined media. This inability is remarkable because, in fact, Gerhardt&#x02019;s medium supports growth of <italic>B. abortus</italic>, <italic>B. melitensis</italic> and <italic>B. suis</italic> biovar 1 better than other simple defined media, including those that contain glucose as C source, and this has been related both to the capability of many <italic>Brucella</italic> strains to carry out gluconeogenesis and to the ability of these bacteria to use glutamate very efficiently through the TCA. Also, the addition of serum and other nutritional complements to Gerhardt&#x02019;s medium did not allow <italic>B. ovis</italic> growth, which means that potential nutrients in serum do not compensate for the complex amino acid and other nutrients present in peptones and yeast extract. This observation together with the impact of <italic>ppdK</italic> deletion in rich medium clearly shows that the metabolism of <italic>B. ovis</italic> differs from those of at least <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> 513, confirming that the internal diversity of the genus may be reflected in the metabolism [<xref ref-type="bibr" rid="CR27">27</xref>]. Significantly, <italic>B. ovis</italic> is defective in the oxidative metabolism of arabinose, galactose, ribose, xylose, glucose, erythritol, fructose and mannose, but all <italic>B. ovis</italic> strains tested are able to oxidize adonitol, a carbohydrate not metabolized by <italic>B. abortus</italic>, <italic>B. suis</italic> and <italic>B. melitensis</italic> [<xref ref-type="bibr" rid="CR43">43</xref>]. Tsolis et al. suggested that the metabolic defects of this species could be related to the inactivation by frameshifts, point mutations or gene degradation of several putative sugar transporters predicted to be functional in other <italic>Brucella</italic> species [<xref ref-type="bibr" rid="CR38">38</xref>], as it is the case of the glucose/galactose transporter GluP, which is almost 100&#x000a0;bp shorter in <italic>B. ovis</italic> due to a point mutation [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par46">The intracellular multiplication of the <italic>ppdK</italic> mutant in macrophages also showed differences with the behavior of the <italic>B. abortus</italic> 2308&#x000a0;W <italic>ppdK</italic> and <italic>B. suis</italic> 513 <italic>pckA</italic>-<italic>ppdK</italic> mutants. While these two mutants were less fit than the parental strains in the replicative niche and did not multiply to their level at 24 and 48&#x000a0;h post-infection [26 and unpublished results], <italic>B. ovis</italic> mutants showed intracellular counts at 20&#x000a0;h significantly higher than those of the parental and complemented strains. This behavior parallels the higher numbers of splenic counts detected at post-infection week 1 for both <italic>ppdK</italic> mutants. Moreover, the level of splenic infection progressively decreased thereafter, which could be related with the lack of significant multiplication of the mutants in phagocytes after 20&#x000a0;h. Resembling the phenotypes of the corresponding mutants in <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> 513, both <italic>ppdK</italic> mutants failed to reach the chronic steady phase typical of virulent brucellae, yielding significantly lower CFU counts after week 1. These results are compatible with the model proposed before for <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> 513 suggesting that in the replicative niche of these bacteria, glutamate, alanine, and other amino acids are important C sources, while a limited supply of 6 and 5 C would be used for biosynthesis of envelope polymers and for the Pentose Phosphate cycle-dependent biosynthetic reactions [<xref ref-type="bibr" rid="CR26">26</xref>]. However, considering the above-discussed metabolic differences with the smooth brucellae, it is necessary to study other <italic>B. ovis</italic> mutants in key enzymes of the glycolytic and gluconeogenic pathways, or the anabolic routes bridging the TCA and the triose-phosphate pathway to support this hypothesis.</p><p id="Par47">It is important to highlight the practical implications of this work. The kinetics of splenic infection observed with the of <italic>B. ovis</italic> PA <italic>ppdK</italic> mutants, with the high numbers of bacterial counts observed at week 1 and persistence until at least week 7, suggests that this mutant might be an interesting vaccine candidate against <italic>B. ovis</italic> infection. A similar profile of splenic infection in mice has been observed for another <italic>B. ovis</italic> attenuated mutant conferring homologous protection in the murine model, and with <italic>B. melitensis</italic> Rev1 [<xref ref-type="bibr" rid="CR20">20</xref>], the classical vaccine used against <italic>B. ovis</italic> infection in sheep [<xref ref-type="bibr" rid="CR10">10</xref>]. Moreover, <italic>B. abortus</italic> 2308&#x000a0;W and <italic>B. suis</italic> biovar 2 <italic>ppdK</italic> mutants showed good potential to immunize against virulent <italic>B. abortus</italic> and <italic>B. suis</italic>, respectively. In fact, both vaccine candidates reached the level of protection of the reference vaccines in the mouse model while showed reduced residual virulence (Z&#x000fa;&#x000f1;iga-Ripa et al., unpublished results and Arag&#x000f3;n-Aranda et al., unpublished results). Therefore, the combination of <italic>ppdK</italic> deletion with the genetic modifications required for CO<sub>2</sub>-independent growth results in an interesting tool to study protection against sheep brucellosis caused by <italic>B. ovis</italic>.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec16"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13567_2020_824_MOESM1_ESM.pdf"><caption><p><bold>Additional file 1: Chemically defined media used in this work</bold>.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13567_2020_824_MOESM2_ESM.pdf"><caption><p><bold>Additional file 2: (A) Amino acid sequence alignment of PckA in</bold>
<bold><italic>A. tumefaciens</italic></bold>
<bold>C58,</bold>
<bold><italic>B. ovis</italic></bold>
<bold>63/290,</bold>
<bold><italic>B. abortus</italic></bold>
<bold>2308 and</bold>
<bold><italic>B. suis</italic></bold>
<bold>513</bold>. In bold and underlined, the specific domain (IGGTSYAGE-KKS; 190 to 202) required for the PckA activity, the phosphate-binding (G--G-GKT; 233 to 243) and adenine-binding (IIML&#x02014;D; 345 to 351) consensus sites of ATP-dependent proteins and the metal ion binding (G----EG; 265 to 271) site. In red, amino acids (419-458) not conserved in <italic>B. ovis</italic> 63/290 due to the deletion of a cytosine at position 1523 of the <italic>pckA</italic> gene. <bold>B</bold> Amino acid sequence alignment of PpdK in <italic>B. ovis</italic> 63/290, <italic>B. abortus</italic> 2308 and <italic>B. suis</italic> 513. In red, the 3 amino acid changes found in <italic>B. ovis</italic> 63/290 in contrast to <italic>B. abortus</italic> 2308W and <italic>B. suis</italic> 513 (A177V, V312E, C857Y).</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AMP</term><def><p id="Par2">adenosine monophosphate</p></def></def-item><def-item><term>ATP</term><def><p id="Par3">adenosine triphosphate</p></def></def-item><def-item><term>HS</term><def><p id="Par4">horse serum</p></def></def-item><def-item><term>KEGG</term><def><p id="Par5">Kyoto Encyclopedia of Genes and Genomes</p></def></def-item><def-item><term>Km</term><def><p id="Par6">kanamycin</p></def></def-item><def-item><term>LPS</term><def><p id="Par7">lipopolysaccharide</p></def></def-item><def-item><term>Nal</term><def><p id="Par8">nalidixic acid</p></def></def-item><def-item><term>NCBI</term><def><p id="Par9">National Center for Biotechnology Information</p></def></def-item><def-item><term>PckA</term><def><p id="Par10">phosphoenolpyruvate carboxykinase</p></def></def-item><def-item><term>PEP</term><def><p id="Par11">phosphoenolpyruvate</p></def></def-item><def-item><term>P.i</term><def><p id="Par12">post-infection</p></def></def-item><def-item><term>PpdK</term><def><p id="Par13">pyruvate phosphate dikinase</p></def></def-item><def-item><term>Pps</term><def><p id="Par14">phosphoenolpyruvate synthase</p></def></def-item><def-item><term>TCA</term><def><p id="Par15">tricarboxylic Acid Cycle</p></def></def-item><def-item><term>TSA</term><def><p id="Par16">tryptic soy agar</p></def></def-item><def-item><term>TSB</term><def><p id="Par17">tryptic soy broth</p></def></def-item><def-item><term>YE</term><def><p id="Par18">yeast extract</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13567-020-00824-7.</p></sec><ack><title>Acknowledgements</title><p>We thank the staff of the animal experimentation facilities of University of Salamanca for their helpful collaboration.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>NV, AZ-R and IM conceived and coordinated the study. NV, LP-E and AZ-R, performed experiments. MI and RC-A supervised the genomic studies. NV, AZ-R and IM wrote the manuscript. All authors analyzed the results and approved the final version of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The work at &#x0201c;Departamento de Microbiolog&#x000ed;a y Gen&#x000e9;tica, Universidad de Salamanca&#x0201d;, was financed by the &#x0201c;Ministerio de Econom&#x000ed;a y Competitividad&#x0201d; (MINECO) of Spain (Grant AGL2014-58795-C4-4-R, cofinanced with FEDER funds). The work at &#x0201c;Departamento de Microbiolog&#x000ed;a y Parasitolog&#x000ed;a, Instituto de Salud Tropical, Universidad de Navarra&#x0201d;, was supported by MINECO (grant AGL2014-58795-C4-1-R) and &#x0201c;Instituto de Salud Tropical&#x0201d; funders (Obra Social la CAIXA -LCF/PR/PR13/11080005- and Fundaci&#x000f3;n Caja Navarra, Fundaci&#x000f3;n Mar&#x000ed;a Francisca de&#x000a0;Roviralta, Ubesol and Inversiones Garcilaso de la Vega S.L).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par48">Procedures in mice were in accordance with Spanish and European laws regarding the use of animals in research (RD 53/2013 and directive 2010/63/UE). They were approved by the Bioethics Committee of the University of Salamanca (Permit number CBE 5) and authorized by the competent authority of &#x0201c;Junta de Castilla y Le&#x000f3;n&#x0201d;, Spain.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par49">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par50">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDermott</surname><given-names>JJ</given-names></name><name><surname>Grace</surname><given-names>D</given-names></name><name><surname>Zinsstag</surname><given-names>J</given-names></name></person-group><article-title>Economics of brucellosis impact and control in low-income countries</article-title><source>Rev Sci Tech</source><year>2013</year><volume>32</volume><fpage>249</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.20506/rst.32.1.2197</pub-id><pub-id pub-id-type="pmid">23837382</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>OIE</collab></person-group><article-title>Ovine epididimytis (<italic>Brucella ovis</italic>)</article-title><source>Manual of Diagnostic Tests and Vaccines for Terrestrial Animals</source><year>2015</year><publisher-loc>Paris</publisher-loc><publisher-name>France</publisher-name><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>Retrospective and prospective perspectives on zoonotic brucellosis</article-title><source>Front Microbiol</source><year>2014</year><volume>5</volume><fpage>213</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00213</pub-id><pub-id pub-id-type="pmid">24860561</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>GW</given-names></name></person-group><article-title>Ovine contagious epididymitis: a review</article-title><source>Vet Microbiol</source><year>1982</year><volume>7</volume><fpage>551</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/0378-1135(82)90049-9</pub-id><pub-id pub-id-type="pmid">6762755</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>TE</given-names></name><name><surname>Berry</surname><given-names>SL</given-names></name><name><surname>Glenn</surname><given-names>JS</given-names></name></person-group><article-title>Economics of <italic>Brucella ovis</italic> control in sheep: epidemiologic simulation model</article-title><source>J Am Vet Med Assoc</source><year>1987</year><volume>190</volume><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">3570957</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasco</surname><given-names>JM</given-names></name><name><surname>Molina-Flores</surname><given-names>B</given-names></name></person-group><article-title>Control and eradication of <italic>Brucella melitensis</italic> infection in sheep and goats</article-title><source>Vet Clin North Am Food Anim Pract</source><year>2011</year><volume>27</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.cvfa.2010.10.003</pub-id><pub-id pub-id-type="pmid">21215893</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasco</surname><given-names>JM</given-names></name><name><surname>D&#x000ed;az</surname><given-names>R</given-names></name></person-group><article-title><italic>Brucella melitensis</italic> Rev-1 vaccine as a cause of human brucellosis</article-title><source>Lancet</source><year>1993</year><volume>342</volume><fpage>805</fpage><pub-id pub-id-type="doi">10.1016/0140-6736(93)91571-3</pub-id><pub-id pub-id-type="pmid">8103891</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariza</surname><given-names>J</given-names></name><name><surname>Bosilkovski</surname><given-names>M</given-names></name><name><surname>Cascio</surname><given-names>A</given-names></name><etal/></person-group><article-title>Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations</article-title><source>PLoS Med</source><year>2007</year><volume>4</volume><fpage>e317</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0040317</pub-id><pub-id pub-id-type="pmid">18162038</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x000ed;n</surname><given-names>CM</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><name><surname>Moriy&#x000f3;n</surname><given-names>I</given-names></name><etal/></person-group><article-title>Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis</article-title><source>Clin Diagn Lab Immunol</source><year>1999</year><volume>6</volume><fpage>269</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1128/cdli.6.2.269-272.1999</pub-id><pub-id pub-id-type="pmid">10066666</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>A review of the use of <italic>B. melitensis</italic> Rev 1 vaccine in adult sheep and goats</article-title><source>Prev Vet Med</source><year>1997</year><volume>31</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/S0167-5877(96)01110-5</pub-id><pub-id pub-id-type="pmid">9234451</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Costa</surname><given-names>Martins R</given-names></name><name><surname>Irache</surname><given-names>JM</given-names></name><name><surname>Gamazo</surname><given-names>C</given-names></name></person-group><article-title>Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease</article-title><source>Expert Rev Vaccines</source><year>2012</year><volume>11</volume><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1586/erv.11.172</pub-id><pub-id pub-id-type="pmid">22149711</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriy&#x000f3;n</surname><given-names>I</given-names></name><name><surname>Grill&#x000f3;</surname><given-names>MJ</given-names></name><name><surname>Monreal</surname><given-names>D</given-names></name><etal/></person-group><article-title>Rough vaccines in animal brucellosis: structural and genetic basis and present status</article-title><source>Vet Res</source><year>2004</year><volume>35</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1051/vetres:2003037</pub-id><pub-id pub-id-type="pmid">15099501</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>APC</given-names></name><name><surname>Mac&#x000ea;do</surname><given-names>AA</given-names></name><name><surname>Costa</surname><given-names>LF</given-names></name><etal/></person-group><article-title><italic>Brucella ovis</italic> lacking a species-specific putative ATP-binding cassette transporter is attenuated but immunogenic in rams</article-title><source>Vet Microbiol</source><year>2013</year><volume>167</volume><fpage>546</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2013.09.003</pub-id><pub-id pub-id-type="pmid">24075357</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Cabello</surname><given-names>A</given-names></name><name><surname>Akoolo</surname><given-names>L</given-names></name><etal/></person-group><article-title>The case for live attenuated vaccines against the neglected zoonotic diseases Brucellosis and Bovine tuberculosis</article-title><source>PLoS Negl Trop Dis</source><year>2016</year><volume>10</volume><fpage>e0004572</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0004572</pub-id><pub-id pub-id-type="pmid">27537413</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>P</given-names></name></person-group><article-title>Brucellosis: past, present and future</article-title><source>Prilozi</source><year>2010</year><volume>31</volume><fpage>21</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">20703181</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-Mart&#x000ed;n</surname><given-names>AI</given-names></name><name><surname>Sancho</surname><given-names>P</given-names></name><name><surname>de Miguel</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Quorum-Sensing and BvrR/BvrS R regulation, the type IV secretion system, cyclic glucans, and BacA in the virulence of <italic>Brucella ovis</italic>: similarities to and differences from smooth Brucellae</article-title><source>Infect Immun</source><year>2012</year><volume>80</volume><fpage>1783</fpage><lpage>1793</lpage><pub-id pub-id-type="doi">10.1128/IAI.06257-11</pub-id><pub-id pub-id-type="pmid">22392933</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caro-Hern&#x000e1;ndez</surname><given-names>P</given-names></name><name><surname>Fern&#x000e1;ndez-Lago</surname><given-names>L</given-names></name><name><surname>De Miguel</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Role of the Omp25/Omp31 family in outer membrane properties and virulence of <italic>Brucella ovis</italic></article-title><source>Infect Immun</source><year>2007</year><volume>75</volume><fpage>4050</fpage><lpage>4061</lpage><pub-id pub-id-type="doi">10.1128/IAI.00486-07</pub-id><pub-id pub-id-type="pmid">17562767</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soler-Llor&#x000e9;ns</surname><given-names>P</given-names></name><name><surname>Gil-Ram&#x000ed;rez</surname><given-names>Y</given-names></name><name><surname>Zabalza-Barangu&#x000e1;</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mutants in the lipopolysaccharide of <italic>Brucella ovis</italic> are attenuated and protect against <italic>B ovis</italic> infection in mice</article-title><source>Vet Res</source><year>2014</year><volume>45</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.1186/s13567-014-0072-0</pub-id><pub-id pub-id-type="pmid">25029920</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>TM</given-names></name><name><surname>Paixao</surname><given-names>TA</given-names></name><name><surname>Costa</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Putative ATP-binding cassette transporter is essential for <italic>Brucella ovis</italic> pathogenesis in mice</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>1706</fpage><lpage>1717</lpage><pub-id pub-id-type="doi">10.1128/IAI.01109-10</pub-id><pub-id pub-id-type="pmid">21300772</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancho</surname><given-names>P</given-names></name><name><surname>Tejedor</surname><given-names>C</given-names></name><name><surname>Sidhu-Mu&#x000f1;oz</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Evaluation in mice of <italic>Brucella ovis</italic> attenuated mutants for use as live vaccines against <italic>B. ovis</italic> infection</article-title><source>Vet Res</source><year>2014</year><volume>45</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1186/1297-9716-45-61</pub-id><pub-id pub-id-type="pmid">24898325</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidhu-Mu&#x000f1;oz</surname><given-names>RS</given-names></name><name><surname>Sancho</surname><given-names>P</given-names></name><name><surname>Cloeckaert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Characterization of cell envelope multiple mutants of <italic>Brucella ovis</italic> and assessment in mice of their vaccine potential</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>2230</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02230</pub-id><pub-id pub-id-type="pmid">30294312</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>APC</given-names></name><name><surname>Mac&#x000ea;do</surname><given-names>AA</given-names></name><name><surname>Costa</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Encapsulated <italic>Brucella ovis</italic> lacking a putative ATP-Binding Cassette transporter (&#x00394;<italic>abcBA</italic>) protects against wild type <italic>Brucella ovis</italic> in rams</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0136865</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0136865</pub-id><pub-id pub-id-type="pmid">26317399</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>APC</given-names></name><name><surname>Mac&#x000ea;do</surname><given-names>AA</given-names></name><name><surname>Silva</surname><given-names>TMA</given-names></name><etal/></person-group><article-title>Protection provided by an encapsulated live attenuated <italic>&#x00394; abcBA</italic> strain of <italic>Brucella ovis</italic> against experimental challenge in a murine model</article-title><source>Clin Vaccine Immunol</source><year>2015</year><volume>22</volume><fpage>789</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1128/CVI.00191-15</pub-id><pub-id pub-id-type="pmid">25947146</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbier</surname><given-names>T</given-names></name><name><surname>Nicolas</surname><given-names>C</given-names></name><name><surname>Letesson</surname><given-names>JJ</given-names></name></person-group><article-title><italic>Brucella</italic> adaptation and survival at the crossroad of metabolism and virulence</article-title><source>FEBS Lett</source><year>2011</year><volume>585</volume><fpage>2929</fpage><lpage>2934</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2011.08.011</pub-id><pub-id pub-id-type="pmid">21864534</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbier</surname><given-names>T</given-names></name><name><surname>Z&#x000fa;&#x000f1;iga-Ripa</surname><given-names>A</given-names></name><name><surname>Moussa</surname><given-names>S</given-names></name><etal/></person-group><article-title><italic>Brucella</italic> central carbon metabolism: an update</article-title><source>Crit Rev Microbiol</source><year>2018</year><volume>44</volume><fpage>182</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2017.1332002</pub-id><pub-id pub-id-type="pmid">28604247</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Z&#x000fa;&#x000f1;iga-Ripa</surname><given-names>A</given-names></name><name><surname>Barbier</surname><given-names>T</given-names></name><name><surname>Conde-&#x000c1;lvarez</surname><given-names>R</given-names></name><etal/></person-group><article-title><italic>Brucella abortus</italic> depends on pyruvate phosphate dikinase and malic enzyme but not on Fbp and GlpX fructose-1,6-bisphosphatases for full virulence in laboratory models</article-title><source>J Bacteriol</source><year>2014</year><volume>196</volume><fpage>3045</fpage><lpage>3057</lpage><pub-id pub-id-type="doi">10.1128/JB.01663-14</pub-id><pub-id pub-id-type="pmid">24936050</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Z&#x000fa;&#x000f1;iga-Ripa</surname><given-names>A</given-names></name><name><surname>Barbier</surname><given-names>T</given-names></name><name><surname>L&#x000e1;zaro-Ant&#x000f3;n</surname><given-names>L</given-names></name><etal/></person-group><article-title>The fast-growing <italic>Brucella suis</italic> biovar 5 depends on phosphoenolpyruvate carboxykinase and pyruvate phosphate dikinase but not on Fbp and GlpX fructose-1,6-bisphosphatases or isocitrate lyase for full virulence in laboratory models</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>641</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.00641</pub-id><pub-id pub-id-type="pmid">29675004</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Etayo</surname><given-names>L</given-names></name><name><surname>de Miguel</surname><given-names>MJ</given-names></name><name><surname>Conde-&#x000c1;lvarez</surname><given-names>R</given-names></name><etal/></person-group><article-title>The CO2-dependence of <italic>Brucella ovis</italic> and <italic>Brucella abortus</italic> biovars is caused by defective carbonic anhydrases</article-title><source>Vet Res</source><year>2018</year><volume>49</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s13567-018-0583-1</pub-id><pub-id pub-id-type="pmid">30185220</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>JB</given-names></name></person-group><article-title>The nutrition of <italic>Brucellae</italic>: growth in simple chemically defined media</article-title><source>J Bacteriol</source><year>1948</year><volume>56</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1128/JB.56.1.17-24.1948</pub-id><pub-id pub-id-type="pmid">16561542</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><etal/></person-group><article-title>Basic local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goujon</surname><given-names>M</given-names></name><name><surname>McWilliam</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>A new bioinformatics analysis tools framework at EMBL-EBI</article-title><source>Nucleic Acids Res</source><year>2010</year><volume>38</volume><fpage>W695</fpage><lpage>W699</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq313</pub-id><pub-id pub-id-type="pmid">20439314</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sievers</surname><given-names>F</given-names></name><name><surname>Wilm</surname><given-names>A</given-names></name><name><surname>Dineen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega</article-title><source>Mol Syst Biol</source><year>2011</year><volume>7</volume><fpage>539</fpage><pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id><pub-id pub-id-type="pmid">21988835</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llobet</surname><given-names>E</given-names></name><name><surname>March</surname><given-names>C</given-names></name><name><surname>Gim&#x000e9;nez</surname><given-names>P</given-names></name><name><surname>Bengoechea</surname><given-names>JA</given-names></name></person-group><article-title><italic>Klebsiella pneumoniae</italic> OmpA confers resistance to antimicrobial peptides</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1128/AAC.00657-08</pub-id><pub-id pub-id-type="pmid">19015361</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-G&#x000f3;mez</surname><given-names>E</given-names></name><name><surname>St&#x000e5;hle</surname><given-names>J</given-names></name><name><surname>Gil-Ram&#x000ed;rez</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genomic insertion of a heterologous acetyltransferase generates a new lipopolysaccharide antigenic structure in <italic>Brucella abortus</italic> and <italic>Brucella melitensis</italic></article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1092</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01092</pub-id><pub-id pub-id-type="pmid">29887851</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidhu-Mu&#x000f1;oz</surname><given-names>RS</given-names></name><name><surname>Sancho</surname><given-names>P</given-names></name><name><surname>Vizca&#x000ed;no</surname><given-names>N</given-names></name></person-group><article-title><italic>Brucella ovis</italic> PA mutants for outer membrane proteins Omp10, Omp19, SP41, and BepC are not altered in their virulence and outer membrane properties</article-title><source>Vet Microbiol</source><year>2016</year><volume>186</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2016.02.010</pub-id><pub-id pub-id-type="pmid">27016758</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Wood</surname><given-names>D</given-names></name><name><surname>Nester</surname><given-names>EW</given-names></name></person-group><article-title>Phosphoenolpyruvate carboxykinase is an acid-induced, chromosomally encoded virulence factor in <italic>Agrobacterium tumefaciens</italic></article-title><source>J Bacteriol</source><year>2005</year><volume>187</volume><fpage>6039</fpage><lpage>6045</lpage><pub-id pub-id-type="doi">10.1128/JB.187.17.6039-6045.2005</pub-id><pub-id pub-id-type="pmid">16109945</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oster&#x000e5;s</surname><given-names>M</given-names></name><name><surname>Driscoll</surname><given-names>BT</given-names></name><name><surname>Finan</surname><given-names>TM</given-names></name></person-group><article-title>Molecular and expression analysis of the <italic>Rhizobium meliloti</italic> phosphoenolpyruvate carboxykinase (<italic>pckA</italic>) gene</article-title><source>J Bacteriol</source><year>1995</year><volume>177</volume><fpage>1452</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1128/JB.177.6.1452-1460.1995</pub-id><pub-id pub-id-type="pmid">7883700</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsolis</surname><given-names>RM</given-names></name><name><surname>Seshadri</surname><given-names>R</given-names></name><name><surname>Santos</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Genome degradation in <italic>Brucella ovis</italic> corresponds with narrowing of its host range and tissue tropism</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e5519</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0005519</pub-id><pub-id pub-id-type="pmid">19436743</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname><given-names>P</given-names></name></person-group><article-title>The nutrition of brucellae</article-title><source>Bacteriol Rev</source><year>1958</year><volume>22</volume><fpage>81</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1128/MMBR.22.2.81-98.1958</pub-id><pub-id pub-id-type="pmid">13546130</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidhu-Mu&#x000f1;oz</surname><given-names>RS</given-names></name><name><surname>Sancho</surname><given-names>P</given-names></name><name><surname>Vizca&#x000ed;no</surname><given-names>N</given-names></name></person-group><article-title>Evaluation of human trophoblasts and ovine testis cell lines for the study of the intracellular pathogen <italic>Brucella ovis</italic></article-title><source>FEMS Microbiol Lett</source><year>2018</year><volume>365</volume><fpage>24</fpage><pub-id pub-id-type="doi">10.1093/femsle/fny278</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grill&#x000f3;</surname><given-names>M-JJ</given-names></name><name><surname>Blasco</surname><given-names>JM</given-names></name><name><surname>Gorvel</surname><given-names>J-PP</given-names></name><etal/></person-group><article-title>What have we learned from brucellosis in the mouse model?</article-title><source>Vet Res</source><year>2012</year><volume>43</volume><fpage>1</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1186/1297-9716-43-29</pub-id><pub-id pub-id-type="pmid">22236452</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez de Bag&#x000fc;&#x000e9;s</surname><given-names>MP</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>CM</given-names></name><name><surname>Barber&#x000e1;n</surname><given-names>M</given-names></name><name><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Evaluation of vaccines and of antigen therapy in a mouse model for <italic>Brucella ovis</italic></article-title><source>Vaccine</source><year>1993</year><volume>11</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/0264-410X(93)90340-4</pub-id><pub-id pub-id-type="pmid">8427038</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>ME</given-names></name></person-group><article-title>Phenotypic comparison of <italic>Brucella ovis</italic> to the DNA-homologous <italic>Brucella species</italic></article-title><source>Am J Vet Res</source><year>1969</year><volume>30</volume><fpage>1757</fpage><lpage>1764</lpage><pub-id pub-id-type="pmid">5824903</pub-id></element-citation></ref></ref-list></back></article>